David Grainger
David Grainger is a partner at medicxi, a European life sciences-oriented venture capital firm and chief executive officer of Methuselah Health Ltd., a drug development company doing proteomics research in the longevity space.He was formerly with Index Ventures, an international venture capital firm with offices in London, Geneva and San Francisco, in the firm's life sciences practice. He also writes for Forbes.com on topics related to the pharmaceutical industry. Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'David Grainger', query time: 0.02s
Refine Results
-
1
-
2
“It’s like going through life at a mediocre level”: a qualitative study of the meaning and impact of fatigue in children and young people with sickle cell disease by Brenda Agyeiwaa Poku, Karl Michael Atkin, John David Grainger, Iyamide Thomas, Rachael Oshinbolu, Abubakar Mohammed, Edith Kyewalyanga, Susan Kirk
Published 2025-05-01Get full text
Article -
3
Urinary bisphenol a concentration and angiography-defined coronary artery stenosis. by David Melzer, Phil Gates, Nicholas J Osborne, William E Henley, Ricardo Cipelli, Anita Young, Cathryn Money, Paul McCormack, Peter Schofield, David Mosedale, David Grainger, Tamara S Galloway
Published 2012-01-01Get full text
Article